Commercialization of an Ultrasound-guided Vascular Access Device

Information

  • Research Project
  • 9702855
  • ApplicationId
    9702855
  • Core Project Number
    R44HL093879
  • Full Project Number
    5R44HL093879-06
  • Serial Number
    093879
  • FOA Number
    RFA-HL-16-009
  • Sub Project Id
  • Project Start Date
    7/15/2011 - 13 years ago
  • Project End Date
    5/31/2021 - 3 years ago
  • Program Officer Name
    BUXTON, DENIS B
  • Budget Start Date
    6/1/2019 - 5 years ago
  • Budget End Date
    5/31/2020 - 4 years ago
  • Fiscal Year
    2019
  • Support Year
    06
  • Suffix
  • Award Notice Date
    8/23/2019 - 5 years ago

Commercialization of an Ultrasound-guided Vascular Access Device

PROJECT SUMMARY Safe and reliable access to major blood vessels and internal organs will be beneficial to patients with cardiovascular and cardiothoracic diseases. An interventional catheter with forward-viewing ultrasound imaging capability will be developed to enable image-guided access to blood vessels and internal organs. Phase 1 and 2 experiments demonstrate feasibility of building a high resolution, forward-viewing ultrasound array and its ability to yield clinical quality images of ex-vivo and in-vivo tissues. This Phase 2B SBIR proposal seeks to build on the Phase 2 results and develop a clinical production grade device. Furthermore, we will demonstrate feasibility and safety of the device in its exemplary clinical uses in preclinical testing and in human studies. The production grade device will meet regulatory and clinical requirements and image quality to produce accurate and safe device guidance to target organs, particularly large blood vessels and the heart. We therefore propose to: a) demonstrate acceptable image quality and biological safety using the go-to-market device, b) demonstrate safety, functionality, and efficacy in vivo using the go-to-market device and, c) establish clinical feasibility and safety profile of the go-to-market device in a human study for its exemplary uses (femoral arterial access, pleural and pericardial access). No such device is currently available in the market and the successful development of a clinically implementable device has immense commercial potential by its ability to contribute significantly to the advancement and expansion of minimally invasive medical procedures.

IC Name
NATIONAL HEART, LUNG, AND BLOOD INSTITUTE
  • Activity
    R44
  • Administering IC
    HL
  • Application Type
    5
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    1026496
  • Sub Project Total Cost
  • ARRA Funded
    False
  • CFDA Code
    837
  • Ed Inst. Type
  • Funding ICs
    NHLBI:1026496\
  • Funding Mechanism
    SBIR-STTR RPGs
  • Study Section
    ZHL1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    PERCEPTIVE NAVIGATION, LLC
  • Organization Department
  • Organization DUNS
    079768582
  • Organization City
    BALTIMORE
  • Organization State
    MD
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    212102724
  • Organization District
    UNITED STATES